Apogee Therapeutics, Inc. Operating Lease, Liability, Current
Apogee Therapeutics, Inc. (APGE) had Operating Lease, Liability, Current of $2.37 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-10
- 2026-06-30: Operating Lease, Liability, Current $2.37M.
- 2026-03-31: Operating Lease, Liability, Current $3.14M.
- 2025-12-31: Operating Lease, Liability, Current $3.50M.
- 2025-09-30: Operating Lease, Liability, Current $4.08M.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $2.37M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $3.14M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $3.50M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $4.08M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $4.03M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $3.98M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $3.23M 10-K · filed 2026-03-02 |
| 2024-09-30 | $2.87M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.68M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $1.14M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $1.10M 10-K · filed 2025-03-03 |